Business ❯ Finance ❯ Securities ❯ Investments

Investor Relations

CarMax Securities Suit Enters Lead-Plaintiff Phase as Jan. 2 Deadline Nears

An amended complaint now extends coverage to Nov. 5 to capture losses from a September earnings shock followed by a leadership change.

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

Freeport-McMoRan Investors Urged to Seek Lead Role in Grasberg Safety Class Action

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

Synopsys Investors Face Dec. 30 Deadline to Seek Lead Role in Securities Class Action

Telix Securities Class Action Draws Flurry of Investor Notices Ahead of Lead-Plaintiff Deadline

Jasper Therapeutics Investors Face Lead Plaintiff Deadline in Securities Class Action

Telix Sued by Investors Over Prostate Therapy Claims After SEC Subpoena and FDA Rejection

Marex Faces Securities Class Action as Firms Urge Investors to Seek Lead Plaintiff by Dec. 8

Multiple Firms File Securities Class Actions Against Telix in Indiana Federal Court Over Prostate Cancer Program Disclosures

MoonLake Investors Courted for Lead Role in SDNY Securities Case After SLK Trial Collapse

KBR Securities Suits Intensify as Firms Urge Investors to Meet Nov. 18 Lead‑Plaintiff Deadline

LifeMD Securities Case Reaches Lead-Plaintiff Deadline as Firms Court Investors

Marex Investors Face Dec. 8 Deadline to Seek Lead Role in Newly Filed Securities Class Action

Cytokinetics Faces Investor Class Action Over Aficamten REMS Disclosures as Lead-Plaintiff Deadline Nears

Charter Faces Securities Class Action Over ACP Disclosures in SDNY

Class Action Targets Fly‑E Over Alleged Battery Safety Misstatements

RxSight Securities Suit Nears Lead-Plaintiff Deadline After 38% Stock Plunge

Alto Neuroscience Investors Urged to Seek Lead Plaintiff Status by Sept. 19